Floatz logo

FUROSEMIDE

Drug-Related Side Effects and Adverse Reactions

European Organisation for Research and Treatment of Cancer - EORTCSmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

12 Active assets in the Drug-Related Side Effects and Adverse Reactions cohort.

Asset / SponsorPhaseRating
Velpatasvir
Alexandria University
Phase 4BB
AUTOLOGOUS CONDITIONED PLASMA
Star Spine and Sport
Phase 4BB
Sofosbuvir
Alexandria University
Phase 4BB
NADROPARIN
Rijnstate Hospital
Phase 4BB
NEPENTHE
Hopital Lariboisière
Phase 4BB

View all 37 →

Same molecule, other indications

FUROSEMIDE is also rated in:

AscitesDormant
BB
Indicative ·
70 / 100
View asset →
cirrhosis of liverDormant
BB
Indicative ·
68 / 100
View asset →
Fluid OverloadDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →